ATLASEupraxia Pharmaceuticals (EPRX) earnings date: Nov 3, 2026
Eupraxia Pharmaceuticals (EPRX) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of -$0.26.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EPRX
| Last price | $6.75 (-1.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Eupraxia Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Eupraxia Pharmaceuticals reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Eupraxia Pharmaceuticals. You can switch it off at any time.
Alert me before EPRX reportsFree to start. Creating an account takes under a minute.
Notify me when Eupraxia Pharmaceuticals reports
Track EPRX free Add Eupraxia Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
EPRX earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.26 |
| Last report | Aug 11, 2026 · In line |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -41.0% |
| Average move around a report | ±3.1% (last 5) |
| Sector | Healthcare · Biotechnology |
Eupraxia Pharmaceuticals earnings history: last 5 reports
Eupraxia Pharmaceuticals last reported on Aug 11, 2026: EPS of -$0.23 against an estimate of -$0.23 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.23 | -$0.23 | 0.0% | In line | -2.7% |
| Jul 29, 2026 | $1.19 | $1.35 | +13.5% | Beat | +7.4% |
| Jul 15, 2026 | $3.14 | $2.81 | -10.5% | Miss | -2.8% |
| Jun 10, 2026 | -$0.77 | -$1.36 | -76.6% | Miss | +1.2% |
| Mar 13, 2026 | -$0.16 | -$0.37 | -131.3% | Miss | -1.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EPRX
See the fair value, the probability range and the earnings history of Eupraxia Pharmaceuticals on its ATLAS page.
Eupraxia Pharmaceuticals (EPRX) stock analysisPlans from €3.99 a month.
Eupraxia Pharmaceuticals earnings: frequently asked questions
When does Eupraxia Pharmaceuticals (EPRX) report earnings?
Eupraxia Pharmaceuticals is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EPRX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.26 per share (USD). Estimates can change before the report.
How often does EPRX beat earnings estimates?
Of its last 5 reports with a recorded result, Eupraxia Pharmaceuticals beat the EPS estimate 1 times; the average surprise was -41.0%. Past results do not predict the next one.
How much does EPRX move around earnings?
Over its last 5 reports the stock moved an average of 3.1% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Eupraxia Pharmaceuticals beat earnings estimates last quarter?
Eupraxia Pharmaceuticals last reported on Aug 11, 2026: EPS of -$0.23 against an estimate of -$0.23 (0.0% surprise), in line with the estimate.
How much does EPRX usually move in a day?
On a normal trading day the ATLAS model puts EPRX’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer